References
- Regitz-Zagrosek V . Sex and gender differences in health. EMBO Rep.13 (7), 596–603 (2012).
- Voskuhl RR , GoldSM. Sex-related factors in multiple sclerosis susceptibility and progression. Nat. Rev. Neurol27, 8 (5), 255–263 (2012).
- Regitz-Zagrosek V . Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat. Rev. Drug Discov.5 (5), 425–438 (2006).
- Gregor Mc K , TempletonAJR, KleinmanM, JenkinsMR. Advancing sex and gender competency in medicine: sex & gender women's health collaborative. Biol. Sex Differ.4, 11–17 (2013).
- Seeland U , Regitz-ZagrosekV. Sex and gender differences in cardiovascular drug therapy. Handb. Exp. Pharmacol.214, 211–236 (2012).
- Franconi F , BrunelleschiS, SteardoL, CuomoV. Gender differences in drug responses. Pharmacol. Res.55 (2), 81–95 (2007).
- Deng X , BerletchJB, NguyenDK, DistecheCM. X chromosome regulation: diverse patterns in development, tissues and disease. Nat. Rev. Genet.15 (6), 367–378 (2014).
- Bhupathy P , HainesCD, LeinwandLA. Influence of sex hormones and phytoestrogens on heart disease in men and women. Womens Health6, 77–95 (2010).
- Rasakham K , Liu-ChenLY. Sex differences in kappa opioid pharmacology. Life Sci.88 (1–2), 2–16 (2011).
- Prossnitz ER , BartonM. The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol.7 (12), 715–726 (2011).
- Thifault E , CormierH, Bouchard-MercierAet al. Effects of age, sex, body mass index and APOE genotype on cardiovascular biomarker response to an n-3 polyunsaturated fatty acid supplementation. J. Nutrigenet. Nutrigenomics6 (2), 73–82 (2013).
- Khan S , ShuklaS, SinhaS, MeeranSM. Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets. Cytokine Growth Factor Rev.24 (6), 503–513 (2013).
- Klein SL . Sex differences in prophylaxis and therapeutic treatments for viral diseases. Handb. Exp. Pharmacol.214, 499–522 (2012).
- Shekhar C , WhorwellPJ. Emerging drugs for irritable bowel syndrome. Expert Opin. Emerg. Drugs14, 673–685 (2009).
- Caranci G , PiscopoP, RivabeneRet al. Gender differences in Parkinson's disease: focus on plasma α-synuclein. J. Neural. Transm.120 (8), 1209–1215 (2013).
- Jamshidi Y et al. Peroxisome proliferator – activated receptor α gene regulates left ventricular growth in response to exercise and hypertension. Circulation105, 950–955 (2002).
- Huang A , KaleyG. Gender-specific regulation of cardiovascular function: estrogen as key player. Microcirculation11 (1), 9–38 (2004).
- Benz V , KintscherU, Foryst-LudwigA. Sex-specific differences in Type 2 Diabetes Mellitus and dyslipidemia therapy: PPAR agonists. Handb. Exp. Pharmacol.214, 387–410 (2012).